Bill Text: IA SF2313 | 2017-2018 | 87th General Assembly | Introduced

---

Bill Title: A bill for an act relating to the medical cannabidiol Act, including by granting the department of public health the authority to alter the definition of medical cannabidiol and to alter the list of debilitating medical conditions for which the use of medical cannabidiol would be medically beneficial, and including conforming changes. (Formerly SSB 3106.)

Spectrum: Committee Bill

Status: (Introduced - Dead) 2018-03-15 - Referred to Judiciary. S.J. 693. [SF2313 Detail]

Download: Iowa-2017-SF2313-Introduced.html

---

Senate File 2313 - Introduced




                                 SENATE FILE       
                                 BY  COMMITTEE ON JUDICIARY

                                 (SUCCESSOR TO SSB
                                     3106)

                                      A BILL FOR

  1 An Act relating to the medical cannabidiol Act, including by
  2    granting the department of public health the authority to
  3    alter the definition of medical cannabidiol and to alter the
  4    list of debilitating medical conditions for which the use
  5    of medical cannabidiol would be medically beneficial, and
  6    including conforming changes.
  7 BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF IOWA:
    TLSB 5906SV (3) 87
    ss/rh

PAG LIN



  1  1    Section 1.  Section 124E.2, subsection 6, Code 2018, is
  1  2 amended to read as follows:
  1  3    6.  "Medical cannabidiol" means any pharmaceutical
  1  4 grade cannabinoid found in the plant Cannabis sativa L. or
  1  5 Cannabis indica or any other preparation thereof that has a
  1  6 tetrahydrocannabinol level of no more than three percent,
  1  7 unless otherwise recommended by the medical cannabidiol board
  1  8 and adopted by the department pursuant to rule, and that is
  1  9 delivered in a form recommended by the medical cannabidiol
  1 10 board, approved by the board of medicine, and adopted by the
  1 11 department pursuant to rule.
  1 12    Sec. 2.  Section 124E.5, subsection 4, Code 2018, is amended
  1 13 to read as follows:
  1 14    4.  a.  Recommendations made by the medical cannabidiol
  1 15 board pursuant to subsection 3, paragraphs paragraph "b" and
  1 16 "e", shall be made to the board of medicine for consideration,
  1 17  department and if approved, shall be adopted by the board of
  1 18 medicine department by rule.
  1 19    b.  Recommendations made by the medical cannabidiol board
  1 20 pursuant to subsection 3, paragraph "e", shall be made to the
  1 21 board of medicine and shall be adopted by the board of medicine
  1 22 by rule.
  1 23    Sec. 3.  Section 124E.5, subsection 6, Code 2018, is amended
  1 24 by striking the subsection.
  1 25    Sec. 4.  Section 124E.11, subsection 2, paragraph c, Code
  1 26 2018, is amended by striking the paragraph.
  1 27                           EXPLANATION
  1 28 The inclusion of this explanation does not constitute agreement with
  1 29 the explanation's substance by the members of the general assembly.
  1 30    This bill grants the medical cannabidiol board authority
  1 31 to recommend to the department of public health alteration
  1 32 of the definition of medical cannabidiol under the medical
  1 33 cannabidiol Act (Code chapter 124E), including the allowable
  1 34 tetrahydrocannabinol (THC) level. The bill also allows the
  1 35 medical cannabidiol board to recommend the alteration of
  2  1 the list of debilitating medical conditions for which the
  2  2 medical use of cannabidiol would be medically beneficial
  2  3 to the department of public health, which shall adopt such
  2  4 recommendations by rule. The bill requires the board of
  2  5 medicine to adopt recommendations made by the medical
  2  6 cannabidiol board regarding the form and quantity of allowable
  2  7 medical uses of marijuana. Current law allows the department
  2  8 of public health to do so following the approval of the board
  2  9 of medicine.
  2 10    The bill strikes current provisions in the law which allow
  2 11 the medical cannabidiol board to recommend increasing the THC
  2 12 level to more than 3 percent to the general assembly and that
  2 13 the general assembly shall have the sole authority to alter the
  2 14 definition of medical cannabidiol.
       LSB 5906SV (3) 87
       ss/rh